WOBURN, Mass., Aug. 30, 2011 /PRNewswire/ -- Avantra Biosciences Corporation today announced that effective immediately it is changing its name to Courtagen Life Sciences, Inc. The company will continue to use the Avantra name for their proteomics portfolio, which includes the Avantra Biomarker System. The Avantra Biomarker System offers users rapid, easy-to-use, quantitative multiplex protein assays using catalog or custom reagents.
Brian McKernan, CEO of Courtagen Life Sciences explained, "The name change reflects the Company's new strategic focus on developing advanced technologies in both genomic and proteomic areas and our commitment to bring additional needed technologies to the market."
In addition to the name change, the company unveiled a new logo and website, www.courtagen.com.
About Courtagen Life Sciences:
Courtagen Life Sciences, Inc. ("CLS") provides innovative and disruptive proteomic and genomic products and services to the Life Sciences industry. Our companies deliver tools that enable researchers and clinicians to make better decisions regarding drug development and patient care.
|SOURCE Courtagen Life Sciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved